Drug profile · INN
tolbutamide sodium
ORINASE DIAGNOSTIC
tolbutamide sodium (ORINASE DIAGNOSTIC) is a sulfonylurea receptor 1, kir6.2 blocker. Route of administration: injection. Current US regulatory status: approved.
Drug details — tolbutamide sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
tolbutamide sodium (ORINASE DIAGNOSTIC) is a sulfonylurea receptor 1, kir6.2 blocker. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Sulfonylurea receptor 1, Kir6.2 blocker
Primary target: Sulfonylurea receptor 1, Kir6.2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is tolbutamide sodium?
tolbutamide sodium (ORINASE DIAGNOSTIC) is a sulfonylurea receptor 1, kir6.2 blocker. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for tolbutamide sodium?
ORINASE DIAGNOSTIC is a marketed brand name for tolbutamide sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tolbutamide sodium?
tolbutamide sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.